82 related articles for article (PubMed ID: 8504277)
1. Transfer by BMT of IgG2 deficiency involving an immunoglobulin heavy chain constant region deletion and a silent IgG2 gene.
Olsson PG; Gustafson R; Hammarström V; Lönnqvist B; Smith CI; Hammarström L
Bone Marrow Transplant; 1993 May; 11(5):409-14. PubMed ID: 8504277
[TBL] [Abstract][Full Text] [Related]
2. Two siblings with deficiency of IgA1, IgG2, IgG4 and IgE due to deletion of immunoglobulin heavy chain constant region genes.
Plebani A; Carbonara AO; Bottaro A; Gallina R; Boccazzi C; Crispino P; Ruggeri L; Soresina A; Meini A; Duina M
Year Immunol; 1993; 7():231-5. PubMed ID: 8372508
[No Abstract] [Full Text] [Related]
3. Immunologic compensation in a patient with a large IgH constant region deletion.
Depiero A; Kaminski DA; Halsey JF; Briles D; Burrows PD; Hostoffer RW
J Allergy Clin Immunol; 2001 Jun; 107(6):1051-5. PubMed ID: 11398084
[TBL] [Abstract][Full Text] [Related]
4. Gene deletion as a cause of associated deficiency of IgA1, IgG2, IgG4 and IgE.
Plebani A; Carbonara AO; Bottaro A; Gallina R; Boccazzi C; Crispino P; Ruggeri L; Salvioni F; Duina M; Negrini A
Immunodeficiency; 1993; 4(1-4):245-8. PubMed ID: 8167710
[No Abstract] [Full Text] [Related]
5. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
6. A recurrent breakpoint in the most common deletion of the Ig heavy chain locus (del A1-GP-G2-G4-E).
Brusco A; Saviozzi S; Cinque F; Bottaro A; DeMarchi M
J Immunol; 1999 Oct; 163(8):4392-8. PubMed ID: 10510380
[TBL] [Abstract][Full Text] [Related]
7. T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up.
Juckett M; Rowlings P; Hessner M; Keever-Taylor C; Burns W; Camitta B; Casper J; Drobyski WR; Hanson G; Horowitz M; Lawton C; Margolis J; Peitryga D; Vesole D
Bone Marrow Transplant; 1998 May; 21(9):893-9. PubMed ID: 9613781
[TBL] [Abstract][Full Text] [Related]
8. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL
Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695
[TBL] [Abstract][Full Text] [Related]
9. The genetics of IgG4 deficiency: role of the immunoglobulin heavy chain constant region and HLA loci.
Gallina R; Bottaro A; Boccazzi C; DeLange G; Danese P; Mazzola G; Amoroso A; DeMarchi M; Carbonara AO
Eur J Immunol; 1992 Jan; 22(1):227-33. PubMed ID: 1346112
[TBL] [Abstract][Full Text] [Related]
10. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
11. Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
Zetterquist H; Mattsson J; Uzunel M; Näsman-Björk I; Svenberg P; Tammik L; Bayat G; Winiarski J; Ringdén O
Bone Marrow Transplant; 2000 Apr; 25(8):843-51. PubMed ID: 10808205
[TBL] [Abstract][Full Text] [Related]
12. Selective IgG2 deficiency due to a point mutation causing abnormal splicing of the Cgamma2 gene.
Zhao Y; Pan-Hammarström Q; Zhao Z; Wen S; Hammarström L
Int Immunol; 2005 Jan; 17(1):95-101. PubMed ID: 15569770
[TBL] [Abstract][Full Text] [Related]
13. Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT).
Frassoni F; Labopin M; Gluckman E; Prentice HG; Vernant JP; Zwaan F; Granena A; Gahrton G; De Witte T; Gratwohl A; Reiffers J; Gorin NC
Bone Marrow Transplant; 1996 Jan; 17(1):13-8. PubMed ID: 8673048
[TBL] [Abstract][Full Text] [Related]
14. Acute graft-versus-host disease after bone marrow transplantation with a single HLA-DPB1*1001 mismatch: involvement of different TCRBV subsets.
Gaschet J; Gallot G; Ibisch C; Lim A; Even J; Vivien R; Hallet MM; Milpied N; Vié H
Bone Marrow Transplant; 1998 Aug; 22(4):385-92. PubMed ID: 9722075
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of selective IgG2 deficiency. The mutated membrane-bound form of gamma2 heavy chain caused complete IGG2 deficiency in two Japanese siblings.
Tashita H; Fukao T; Kaneko H; Teramoto T; Inoue R; Kasahara K; Kondo N
J Clin Invest; 1998 Feb; 101(3):677-81. PubMed ID: 9449702
[TBL] [Abstract][Full Text] [Related]
16. Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia.
Vicent MG; Madero L; Ortega JJ; Martinez A; Gomez P; Verdeguer A; Badell I; Muñoz A; Olive T; Maldonado MS; Bureo E; Cubells J; Diaz MA;
Bone Marrow Transplant; 2002 Jul; 30(1):9-13. PubMed ID: 12105771
[TBL] [Abstract][Full Text] [Related]
17. Gene deletions in the human immunoglobulin heavy chain constant region locus: molecular and immunological analysis.
Lefranc MP; Hammarström L; Smith CI; Lefranc G
Immunodefic Rev; 1991; 2(4):265-81. PubMed ID: 1905558
[TBL] [Abstract][Full Text] [Related]
18. [Basedow disease occurring after allogeneic bone marrow transplantation for acute lymphoblastic leukemia].
Sasaki Y; Ito K
Rinsho Ketsueki; 2002 Sep; 43(9):833-5. PubMed ID: 12412287
[TBL] [Abstract][Full Text] [Related]
19. Molecular and serologic analysis of IgG1 deficiency caused by new forms of the constant region of the Ig H chain gene deletions.
Smith CI; Hammarström L; Henter JI; de Lange GG
J Immunol; 1989 Jun; 142(12):4514-9. PubMed ID: 2498432
[TBL] [Abstract][Full Text] [Related]
20. Human IGHC locus restriction fragment length polymorphisms in IgG4 deficiency: evidence for a structural IGHC defect.
Bottaro A; DeMarchi M; DeLange GG; Boccazzi C; Fubini L; Borra C; Cappello N; Carbonara AO
Eur J Immunol; 1989 Nov; 19(11):2159-62. PubMed ID: 2574682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
